<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>1 </plain></SENT>
<SENT sid="1" pm="."><plain>Intravenous doses of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> (3.4 mumol/kg) were given to <z:mpath ids='MPATH_458'>normal</z:mpath> subjects and patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Both groups displayed an identical initial disappearance of a substantial proportion of the <z:chebi fb="0" ids="16990">bilirubin</z:chebi> but, late in time, the Gilbert's patients exhibited reduced clearance with a sustained elevation of the plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> and no reflux into the plasma space of conjugated <z:chebi fb="0" ids="16990">bilirubin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Increasing the dose in <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (by factors of 3 and 6) failed to reproduce the response found in the Gilbert's patients </plain></SENT>
<SENT sid="4" pm="."><plain>2 </plain></SENT>
<SENT sid="5" pm="."><plain>In the the bile-containing duodenal aspirates of Gilbert's patients the average proportion of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> found as <z:chebi fb="0" ids="16990">bilirubin</z:chebi> diglucuronide was 68% (<z:mpath ids='MPATH_458'>normal</z:mpath> 88%) and of <z:chebi fb="0" ids="16990">bilirubin</z:chebi> monoglucuronide, 23% (<z:mpath ids='MPATH_458'>normal</z:mpath> 7%) </plain></SENT>
<SENT sid="6" pm="."><plain>Both differences were significant at the P less than 0.001 level </plain></SENT>
<SENT sid="7" pm="."><plain>In the Gilbert's patients restriction of caloric intake to 1569 kJ/day for 2 days characteristically raised the serum bilirbuin with no modification of the biliary pigment pattern; <z:chebi fb="1" ids="8069">phenobarbital</z:chebi> (180 mg/day for 2 weeks) decreased the plasma <z:chebi fb="0" ids="16990">bilirubin</z:chebi> to the <z:mpath ids='MPATH_458'>normal</z:mpath> range with, concomitantly, a reversion of the biliary pigment pattern towards <z:mpath ids='MPATH_458'>normal</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>3 </plain></SENT>
<SENT sid="9" pm="."><plain>We conclude that there is no hepatic uptake defect in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> but that there is decreased activity in the conjugation process underlying the addition of the second <z:chebi fb="0" ids="24298">glucuronic acid</z:chebi> moiety to <z:chebi fb="0" ids="16990">bilirubin</z:chebi>, to form <z:chebi fb="0" ids="16990">bilirubin</z:chebi> diglucuronide </plain></SENT>
</text></document>